Project

Ibritumomab tiuxetan and high-dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy. A multicenter phase I trial

Completed · 2006 until 2010

Hitz Felicitas, Demmer-Steingruber Ruth